A critical discovery in cancer investigation is occurring with the use of VHH fragments to reactivate damaged p53. This essential tumor inhibitor protein is frequently inactivated in many forms of malignancies, leading https://mylittlebookmark.com/story7760959/mini-antibodies-restore-the-p53-protein-a-potential-hope-for-cancer-management